NEW YORK & MAINZ, Germany–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization…
A new Equity, Diversity and Inclusion Editorial Board was announced in the American Heart Association’s second annual Disparities issue in the journal Circulation. Eldrin F. Lewis, MD, MPH, Khadijah Breathett, MD,…
American Heart Association The American Heart Association’s flagship journal Circulation published its second annual issue devoted to disparities in cardiovascular medicine. The special issue is a complementary collection of On…
THOUSAND OAKS, Calif., Aug. 29, 2022 /PRNewswire/ — Amgen (NASDAQ:AMGN) today presented new compelling data from the Phase 3 FOURIER open label extension (OLE) studies of Repatha® (evolocumab) in adults with atherosclerotic cardiovascular disease (ASCVD)…
WASHINGTON, June 25, 2022 – The following is a statement from the Association of Black Cardiologists (ABC) regarding the United States Supreme Court decision in the case of Dobbs v.…